Search | The Pirbright Institute

Filters

Scientists join forces to halt the spread of African swine fever in Europe

Leading researchers from The Pirbright Institute have joined with other European scientists to share knowledge and expertise as part of an international collaboration to prevent the spread of African swine fever (ASF). The Institute recently hosted an international workshop…

HRH The Princess Royal officially opens the BBSRC National Vaccinology Centre

HRH The Princess Royal officially opened the BBSRC National Vaccinology Centre: The Jenner Building today (24 March, 2017) – a world leading vaccine development facility, located at The Pirbright Institute in Surrey. The BBSRC National Vaccinology Centre accommodates 100…

Syringe and vaccine vials

New effective vaccine breakthrough in bovine respiratory disease has potential to protect humans

Scientists have made a breakthrough in the search for an effective vaccine for bovine respiratory syncytial virus (bRSV), which could also be effective against the human form of the disease that can be dangerous for infants and the elderly. Working as part of a collaboration…

Dr. Bryan Charleston appointed as Director of The Pirbright Institute

Dr. Bryan Charleston, has been appointed as Institute Director for The Pirbright Institute, a world-leading centre for the prevention and control of viral diseases of livestock, which receives strategic investment from the Biotechnology and Biological Sciences Research…

Technique used to generate new goat genome assembly sets the standard for future projects.

An international scientific collaboration, including expert geneticists from The Pirbright Institute, has generated a new goat genome assembly which is the most complete produced for any mammal to date. By using a combination of techniques in parallel, the approach could…

Plowright building

BBSRC investment a “vote of confidence” in Pirbright’s globally important bioscience

Leading scientists at The Pirbright Institute have welcomed the confirmation of funding for its key scientific research programmes for the next five years from the Biotechnology and Biological Sciences Research Council (BBSRC), which was officially announced today. Pirbright…

Close up of a pipette tip in a well of gel electrophoresis. Blue liquid is visible in the wells.

Nurturing emerging leaders in science

Two talented Pirbright researchers have been awarded with Strategic Career Development Awards (SCDAs) to advance their research and career trajectories. Dr Rory Fortes de Brito, a Senior Postdoctoral researcher in the Porcine Reproductive and Respiratory Syndrome (PRRS)…

First industry guidance on safe working with arthropods and GM insects launched

The first industry guidance on working safely with arthropods and genetically modified (GM) insects was officially launched today (21 April, 2017) at The Pirbright Institute. `Safe working with arthropods: Containment and control for work with uninfected, infected and…

Pandemic threat to humans from common bird flu virus H9N2 better understood

Experiments by researchers at The Pirbright Institute have identified the molecular mechanisms that enable H9N2 viruses - the most common type of avian influenza (bird flu) virus - to infect humans, helping improve risk assessments for its potential to cause pandemic…

New model determining vectors for bluetongue and Schmallenberg will help control outbreaks

A new model developed by scientists at The Pirbright Institute has enabled researchers to determine the method of transmission for bluetongue and Schmallenberg viral diseases for the first time, which they believe will significantly improve efforts to control disease…